Member Info for Energyshares

Little note on check out page:
Spend £3000/€3500/$4000 and enter discount code XMAS-21 to receive our Christmas Hamper

What’s in the Hamper:
A) Jim Bethell’s phone
B) Missing page of Boris speech
C) Brand new Brochure with Swab spelt with a (b)

:):)

That’s what I mean Timster
If still suspended in UK ,Avacta would of included that in their footnote.

Just got home trying to catch up.
Just down loaded the document from the Avacta tweet.

Footnote on every page states:

Avacta® is a registered trademark of Avacta Limited
Professional Use Only Not available for sale in the United States

Brochure Type-01275 AffiDX_Delta Variant Application Note v1
3
SARS-CoV-2 RT-PCR test
100%
SARS-CoV-2 Delta VOC RT-PCR test
100%
AffiDX® Rapid Antigen Test 100%

Does this mean we can sell in UK again.
Only States not for sale in the United States.

If we were still suspended in UK it should say:

Not available for sale in the United States or UK.

When they receive HUA dumbo

With all the noise on here and twitter about BrochureGate it’s easy for new investors not to see the bigger picture with Avacta.
Oncology
Ava6000 plus
preCISION Velcade
preCIDION Paclitaxel
preCISION Oxaliplatin
preCISION Gemcitabine
preCISION Capecitabine
preCISION PARP inhibitor
preCISION PD-1 inhibitor
preCISION AKT inhibitor
preCISION Balixafortide
On top of that lot we have TMAC Programme.
Major licences:
LG Chem worth up to $400m. LG Chem has potentially 8 new products.
multi-target collaboration with LG Chem incorporating Avacta's Affimer XT™ serum half-life extension and LG Chem has Affimer PD-L1 inhibitor totalling $98million
The expanded partnership also provides LG Chem with rights to develop and commercialise other Affimer and non-Affimer biotherapeutics combined with Affimer XT half-life extension for a range of indications and Avacta could earn an additional $55m in milestone payments for each of these new products.
Daewoong x 2
Gene & stem cell with other targets.
Plus a JV with Daewoong AffyXell Therapeutics which was developed by Avacta and Daewoong as a Joint Venture to develop novel mesenchymal stem cell (MSC) therapies.
Point Biopharma, with access to its pre|CISION technology.
Moderna x 1
exclusive license agreement with respect to certain Affimer molecules.
Astrea x 1
Deepverge x 1
Biokit x 1
Abcam x 1
Bioserve x 1

Affidx Portfolio
Covid x 5
Affidx, Bams,Elisa,
Meduflow through Medusa 19 ,Mologic combination test.
Plus in house pipe line non-COVID diagnostic tests, which include assays for D-dimer, cortisol, vitamins D and B12 and CRP.

Look at the big picture it’s Not just about Covid.
If one of the major pharmaceuticals does takeover Avacta then affimers will be all over the news and replacing antibodies a lot quicker.
DYOR.

This is the leaflet for Mologic 11811125

https://mologic.co.uk/wp-content/uploads/2021/03/ML210309-Covid-19-Rapid-Antigen-Test-IFU-GERMAN.pdf

Thanks Poirot like you just trying to help other share holders

Sorry if that document had already been posted , I hadn’t seen it before but it is factual and a few like myself could of missed it.
Not like some hearsay from the local derby & joan club.

Ophidian
The paper is dated Jan 21
I have kept up, just trying to end brochuregate with some other Avacta news

Avacta not happy with producing cancer therapeutics looks like they want a diagnostic tests for cancer detection.

https://www.nature.com/articles/s41598-020-80354-6

Just found this don’t know if it’s been posted on here before but Affimers are the dogs B0ll0cks.

Hats off to Dr Tomlinson he has championed affimers for years.

Hope they will replace antibodies in the near future.

https://hummedia.manchester.ac.uk/institutes/micra/seedcorn/2017awards/1-aiming%20a%20blow%20against%20tissue%20ageing-%20Targeting%20the%20%CE%B1V%CE%B28%20integrin.pdf

Fiona Bruce is working on the brochure for her new series.

If it’s fake it’s very good.
But if it is real I like this last bullet point.

100% sensitivity in clinical study on patients with the DELTA variant.

My concerns about Meduflow name:

Affidx was rejected for a patent in USA because it was similar to another company.

When you google Meduflow results you receive are for another American company
Mediflow manufacturers of water pillows.
I hope USA Patent office don’t reject Meduflow as they did with Affidx.

There will be a few Troll Phantom Flan Flingers on here today trying to get the price back down. :)

Let’s hope whoever did the artwork for the brochure,didn’t do the artwork for the HUA leaflet.

swap - swab

I was more a Tiswas than Swapshop. :);)

They used same legal company to register medusa19 name

https://www.trademarkelite.com/europe/trademark/trademark-detail/018325216/MEDUSA-19

Get up ASAP Jupiter or you will be kicked past Pluto. :) :)

Let’s not forget Affidx is the Brand name of Avacta’s diagnostic portfolio.
Each test produced each medical condition will have a different name .
Onwards Avacta

Race1st

A ******, a sexist and a liar walk into a pub.
The barman asks..
“What are you having,
Mr Johnson”?